Suzanne Hendrix

Assessing clinical meaningfulness with ‘time saved’ in Alzheimer’s disease

The power of composite tests to track Alzheimer’s disease progression

Trends in the use of surrogate biomarkers during clinical trials

Futility analysis in clinical trials: practical and ethical considerations

Symptomatic versus disease modifying treatments

Distinguishing between disease modifying and symptomatic effects in clinical trials